Skip to content
TrustList
British Patient Capital cover

About British Patient Capital

Innovative high-growth companies in our underlying portfolio (as at 31 March 2022) Total commitments to date (as at 31 March 2022)

Latest news & insights

British Patient Capital invests $7m in immuno-oncology specialist Grey Wolf Therapeutics

British Patient Capital and Mubadala Invest in SV Biotech Crossover Opportunities Fund

British Patient Capital invests £8.7m in Perspectum’s Series C funding round

Categories & features

Ask TrustList to introduce you to British Patient Capital

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of British Patient Capital

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about British Patient Capital.

British Patient Capital alternatives

Similar listings buyers compare against this one.